tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

PRPH Stock Latest News

ProPhase Labs hires Dr. Matthew Halpert to Drive Company’s Key Therapeutic and Diagnostic Oncology Programs
Press ReleasesProPhase Labs hires Dr. Matthew Halpert to Drive Company’s Key Therapeutic and Diagnostic Oncology Programs
25d ago
PRPH
ProPhase Labs provides update on progress, development for LB-1
The FlyProPhase Labs provides update on progress, development for LB-1
30d ago
PRPH
ProPhase Labs’ Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancers
Press ReleasesProPhase Labs’ Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancers
30d ago
PRPH
ProPhase Labs CEO Ted Karkus Named One of Inc Magazine’s 10 Most Innovative Healthcare Leaders to Watch in 2023
Press ReleasesProPhase Labs CEO Ted Karkus Named One of Inc Magazine’s 10 Most Innovative Healthcare Leaders to Watch in 2023
1M ago
PRPH
ProPhase Labs Announces Launch of Redesigned Corporate Website
Press ReleasesProPhase Labs Announces Launch of Redesigned Corporate Website
1M ago
PRPH
ProPhase Labs announces launch of redesigned corporate site
The FlyProPhase Labs announces launch of redesigned corporate site
1M ago
PRPH
ProPhase Labs making progress on multiple fronts, says H.C. Wainwright
The FlyProPhase Labs making progress on multiple fronts, says H.C. Wainwright
2M ago
PRPH
ProPhase Labs reports 2022 EPS $1.02 vs. 40c last year
The FlyProPhase Labs reports 2022 EPS $1.02 vs. 40c last year
2M ago
PRPH
ProPhase Labs Announces Record Financial Results for the year ended December 31, 2022
Press ReleasesProPhase Labs Announces Record Financial Results for the year ended December 31, 2022
2M ago
PRPH
Prophase Labs (PRPH) Q4 Earnings Cheat Sheet
Pre-EarningsProphase Labs (PRPH) Q4 Earnings Cheat Sheet
2M ago
PRPH
ProPhase Labs announces $6M stock repurchase program
The FlyProPhase Labs announces $6M stock repurchase program
3M ago
PRPH
ProPhase Labs announces data presentation on BE-smart Test
The FlyProPhase Labs announces data presentation on BE-smart Test
3M ago
PRPH
ProPhase Labs’ Nebula Genomics introduces lowest NGS pricing
The FlyProPhase Labs’ Nebula Genomics introduces lowest NGS pricing
3M ago
PRPH
DSS ProPhase Labs announces letter to shareholders
The FlyDSS ProPhase Labs announces letter to shareholders
3M ago
DSS
PRPH
ProPhase Labs announces collaboration with mProbe
The FlyProPhase Labs announces collaboration with mProbe
3M ago
PRPH
ProPhase Labs announces plans to initiate clinical trial of Equivir OTC
The FlyProPhase Labs announces plans to initiate clinical trial of Equivir OTC
3M ago
PRPH
ProPhase Labs announces its BE-smart featured in peer-reviewed article
The FlyProPhase Labs announces its BE-smart featured in peer-reviewed article
4M ago
PRPH
ProPhase Labs to expand Pharmaloz Manufacturing subsidiary
The FlyProPhase Labs to expand Pharmaloz Manufacturing subsidiary
4M ago
PRPH
ProPhase Labs provides update on Linebacker-1 cancer co-therapy program
The FlyProPhase Labs provides update on Linebacker-1 cancer co-therapy program
4M ago
PRPH
ProPhase Labs closes acquisition of BE-Smart Esophageal Pre-Cancer test
The FlyProPhase Labs closes acquisition of BE-Smart Esophageal Pre-Cancer test
5M ago
PRPH
ProPhase Labs acquires rights to BE-Smart Esophageal Pre-Cancer test
The FlyProPhase Labs acquires rights to BE-Smart Esophageal Pre-Cancer test
5M ago
PRPH
ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
Press ReleasesProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
5M ago
PRPH